Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 6, 2007, Pages 817-820

  Gaedigk, A ^a   Eklund, J D ^a   Pearce, R E ^a   Leeder, J S ^a   Alander, S W ^a   Phillips, M S ^b   Bradford, L D ^c   Kennedy, M J ^d  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DRUG METABOLISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 34249034315     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100125     Document Type: Article

References (14)

1. Gaedigk, A., Alander, S.W., Bradford, L.D. & Leeder, J.S. CYP2D6*36 gene arrangements within the CYP2D6 locus: association of CYP2D6*36 with poor metabolizer status. Drug Metab. Dispos. 34, 563-569 (2006).
2. Gaedigk, A. et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin. Pharmacol. Ther. 81, 242-251 (2007).
3. Li, L. et al. New cytochrome P450 2D6*56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes. Drug Metab. Dispos. 34, 1411-1416 (2006).
4. Gaedigk, A., Bradford, L.D., Marcucci, K.A. & Leeder, J.S. Unique CYP2D6 activity distribution and genotype-phenotype discordance in African Americans. Clin. Pharmacol. Ther. 72, 76-89 (2002).
5. Gaedigk, A., Ndjountsche, L., Gaedigk, R., Bradford, L.D. & Leeder, J.S. Discovery of a novel non-functional cytochrome P4502D6 allele, CYP2D6*42, in African Americans. Clin. Pharmacol. Ther. 73, 575-576 (2003).
6. Wang, S.-L., Lai, M.-D. & Huang, J.-D. G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab. Dispos. 27, 385-388 (1999).
7. Ji, L. et al. Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14b allele in mainland Chinese. Clin. Chem. 48, 983-988 (2002).
8. Yokoi, T. et al. A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype. Pharmacogenetics 6, 395-401 (1996).
9. Yamazaki, H. et al. Two novel haplotypes of CYP2D6 gene in a Japanese population. Drug Metab. Pharmacokinet. 18, 269-271 (2003).
10. Blake, M.J., Abdel-Rahman, S.M., Pearce, R.E., Leeder, S.J. & Kearns, G.L. Effect of diet on the development of drug metabolism in healthy infants. Pediatr. Res. 60, 717-723 (2006).
11. Gaedigk, A. et al. Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J. 5, 173-182 (2005).
12. Gaedigk, A., Ndjountsché, L., Leeder, J.S. & Bradford, L.D. Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects. Clin. Pharmacol. Ther. 77, 228-230 (2005).
13. Gaedigk, A., Gotschall, R.R., Forbes, N.S., Simon, S.D. & Leeder, J.S. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 9, 669-682 (1999).
14. Kennedy, M.-J. et al. Chronic intermittent nocturnal hypoxemia alters activirties of hepatic cytochrome P4501A2 (CYP1A2), N- acetyltransferase 2 (NAT2), and xanthine oxidase (XO) in children with obstructive sleep apnea (OSA). Clin. Pharmacol. Ther. 79, 33 (2006).